EKSO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Ekso Bionics Holdings Inc (EKSO) is not a strong buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The lack of positive catalysts, weak financial performance, and absence of trading signals suggest that holding off on this stock is prudent at this time.
The stock's MACD is below 0 and negatively contracting, indicating bearish momentum. RSI is neutral at 51.087, and moving averages are converging, suggesting no clear trend. Key support is at 10.137, and resistance is at 12.231. Overall, the technical indicators do not signal a strong buying opportunity.
NULL identified. No recent news or significant trading trends from hedge funds or insiders.
EPS also declined by -29.47% YoY. The stock has a 60% chance of declining by -0.57% in the next day and -3.49% in the next month.
In Q4 2025, revenue dropped to $3,140,000 (-38.31% YoY), while net income improved to -$4,674,000 (+36.95% YoY). EPS dropped to -1.46 (-29.47% YoY), and gross margin slightly declined to 53.22% (-0.19% YoY). Overall, the financial performance shows declining growth trends.
No analyst rating or price target data available.
